Patents by Inventor Ayodeji Asuni

Ayodeji Asuni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunotherapy for Clearing Pathological Tau Conformers
    Publication number: 20200190173
    Abstract: The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.
    Type: Application
    Filed: July 3, 2019
    Publication date: June 18, 2020
    Applicant: New York University
    Inventors: Einar M. Sigurdsson, Ayodeji Asuni
  • Immunotherapy for Clearing Pathological Tau Conformers
    Publication number: 20180002414
    Abstract: The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.
    Type: Application
    Filed: August 17, 2017
    Publication date: January 4, 2018
    Applicant: New York University
    Inventors: Einar M. Sigurdsson, Ayodeji Asuni
  • Immunotherapy for clearing pathological tau conformers
    Patent number: 9777056
    Abstract: The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: October 3, 2017
    Assignee: New York University
    Inventors: Einar M. Sigurdsson, Ayodeji Asuni
  • Immunotherapy for Clearing Pathological Tau Conformers
    Publication number: 20150368328
    Abstract: The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.
    Type: Application
    Filed: August 24, 2015
    Publication date: December 24, 2015
    Applicant: NEW YORK UNIVERSITY
    Inventors: Einar M. Sigurdsson, Ayodeji Asuni
  • Immunotherapy for clearing pathological tau conformers
    Patent number: 9139643
    Abstract: The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of aggregates from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: September 22, 2015
    Assignee: New York University
    Inventors: Einar Sigurdsson, Ayodeji Asuni
  • IMMUNOTHERAPY FOR CLEARING PATHOLOGICAL TAU CONFORMERS
    Publication number: 20110318358
    Abstract: The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of aggregates from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.
    Type: Application
    Filed: September 2, 2011
    Publication date: December 29, 2011
    Applicant: NEW YORK UNIVERSITY
    Inventors: Einar SIGURDSSON, Ayodeji ASUNI
  • Tau fragments for immunotherapy
    Patent number: 8012936
    Abstract: The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of aggregates from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: September 6, 2011
    Assignee: New York University
    Inventors: Einar Sigurdsson, Ayodeji Asuni
  • IMMUNOTHERAPY FOR CLEARING PATHOLOGICAL TAU CONFORMERS
    Publication number: 20080050383
    Abstract: The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions effective to treat or prevent Alzheimer's Disease of other tauopathies. Also disclosed are methods of promoting clearance of aggregates from the brain of the subject and of slowing progression of tangle-related behavioral phenotype in a subject.
    Type: Application
    Filed: March 29, 2007
    Publication date: February 28, 2008
    Applicant: NEW YORK UNIVERSITY
    Inventors: Einar SIGURDSSON, Ayodeji ASUNI